Instil Bio, Inc.

NASDAQ:TIL

20.83 (USD) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 000007.670000000000000.0520.0420.044
Cost of Revenue 00010.9931.0360.9530.8352.0470.8072.4050.9791.7960.8930.7640.6560.4390000
Gross Profit 000-1-0.9936.634-0.953-0.835-2.047-0.807-2.405-0.979-1.796-0.893-0.764-0.656-0.43900.0520.0420.044
Gross Profit Ratio 000000.865000000000000111
Reseach & Development Expenses 5.3711.099102.9217.2561.9838.4928.45920.6720.72239.6641.539.17442.57729.06421.18614.42410.2474.9082.2372.007
General & Administrative Expenses 9.10910.37310.70710.70612.42410.87211.94111.51813.22212.9116.98917.22415.11211.17513.9614.1958.9797.232.8552.3981.9
Selling & Marketing Expenses 0000-0.993-1.036000000000000000
SG&A 9.10910.37310.70710.70611.4319.83611.94111.51813.22212.9116.98917.22415.11211.17513.9614.1958.9797.232.8552.3981.9
Other Expenses 16.0820.3472.924-1-0.428-0.1246.2830.628-0.0571.299-0.415-1.032-0.319-0.5380000000
Operating Expenses 30.56210.73123.63112.62718.68711.81966.71619.97733.89233.63256.64958.72454.28653.75243.02435.38123.40317.4777.7634.6353.907
Operating Income -30.562-11.819-23.631-13.627-19.68-12.855-66.716-20.987-58.446-56.799-56.649-58.724-54.286-53.752-43.024-35.381-23.403-17.477-7.711-4.593-3.863
Operating Income Ratio 00000-1.676000000000000-148.288-109.357-87.795
Total Other Income Expenses Net 2.362-0.0760.61-1.29-4.622-0.07-0.7162.3251.3782.350.054-0.877-0.319-0.538-0.639-0.0890.0710.4430.449-4.609-0.226
Income Before Tax -28.2-11.895-23.021-14.917-24.302-12.925-67.432-18.662-57.068-54.449-56.595-59.601-54.605-54.29-43.663-35.47-23.332-17.034-7.262-9.202-4.089
Income Before Tax Ratio 00000-1.685000000000000-139.654-219.095-92.932
Income Tax Expense 0-0.95000.951.468-0.9530.227-0.742-0.605-0.371-0.609-0.4881.06-0.658-0.159-0.2040.151-0.4494.6090.226
Net Income -28.2-11.895-23.021-14.917-24.302-12.925-67.432-18.662-56.326-53.844-56.224-58.992-54.117-55.35-43.005-35.311-23.128-17.185-7.262-9.202-4.089
Net Income Ratio 00000-1.685000000000000-139.654-219.095-92.932
EPS -4.32-1.82-3.54-2.29-3.74-1.99-10.37-2.87-8.66-8.29-0.43-0.46-0.42-0.43-0.33-0.27-0.66-0.49-0.12-0.15-0.066
EPS Diluted -4.32-1.82-3.54-2.29-3.74-1.99-10.37-2.87-8.66-8.29-0.43-0.46-0.42-0.43-0.33-0.27-0.66-0.49-0.12-0.15-0.066
EBITDA -30.562-8.564-20.114-11.918-21.577-9.909-64.476-17.237-54.385-52.897-53.383-58.724-52.809-53.397-42.899-34.814-22.893-17.329-7.644-4.559-3.856
EBITDA Ratio 00000-1.292000000000000-147-108.548-87.636